Transpek's R&D and quality chief Gurpreet Kaur resigns
The head of R&D and Quality Control quit on two days' notice, citing professional circumstances. The loss comes as the micro-cap chemicals firm faces declining revenue and profit.
— 1 earlier story on Transpek Industry Ltd. →What's new
- Dr. Gurpreet Kaur resigned as Senior General Manager of R&D and Quality Control, effective July 15.
- She cited professional circumstances and gave only two days' notice.
- The company accepted the resignation; no replacement has been announced.
Why this matters
For a specialty chemicals company, R&D and quality control are critical. The short notice and 'professional circumstances' raise questions, but no disruption is indicated yet. With revenue down 10.3% and PAT down 65.8% in the trailing twelve months, this departure adds another layer of uncertainty.
What we're watching
- Whether a replacement for R&D and QC is appointed quickly.
- Any impact on product development pipeline or quality certifications.
- The next quarterly results for signs of operational disruption.
The full read
Transpek Industry has lost its top R&D and quality executive. Dr. Gurpreet Kaur, Senior General Manager of R&D and Quality Control, resigned on July 13 and will be relieved by July 15 — a notice period of just two days. Her resignation letter cited 'professional circumstances', a phrase that offers no clarity. While the company accepted the resignation without fuss, the timing is awkward. Transpek is a micro-cap with a market cap of ₹570 cr, and its trailing numbers are ugly: revenue down 10.3% and net profit down 65.8%. The company is not cash-stressed — debt is negligible and it just declared a ₹20 per share dividend. But for a chemicals business, R&D and quality are the backbone. The departure of the person running both functions, with no successor named, is a personnel risk that amplifies the existing financial strain. It's not a crisis, but every key person matters more when the business is already under pressure.
Questions answered
- Why did Gurpreet Kaur resign?
- She cited professional circumstances in her resignation letter. No further details were provided.
- How significant is this role for Transpek?
- As head of R&D and Quality Control, she oversaw product development and quality assurance, both critical for a chemicals firm. However, the company has not indicated any material impact.
- Has the company named a successor?
- No, the filing only stated that the resignation was accepted. It did not announce a replacement.
- What is Transpek's recent financial performance?
- Transpek has a market cap of ₹570 cr and low debt. But trailing revenue fell 10.3% and net profit fell 65.8% in the latest twelve months.
- Should investors be concerned about this resignation?
- Not immediately, but the short notice and the company's existing headwinds make it a development worth monitoring.
Transpek Industry Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on TRANSPEK →- 13 Jul 2026 · 5:01 PM IST Transpek's R&D and quality chief Gurpreet Kaur resigns
- 52d ago Transpek Industry declares ₹20 per share dividend